Return to search

A Study on Reversing the Immunosuppressive Phenotype of Tumor Associated Macrophages

Extracellular stimuli may influence the M1/M2 phenotypic polarization of
macrophages. We examined M1/M2 biomarkers, phagocytic activity, and tumoricidal
activity in RAW 264.7 mouse macrophages. Macrophages were treated with conditioned
media (CM) from 4T1 breast cancer cells, curcumin, 22-oxacalcitriol, LPS, or a
combination of the previously listed. Arginase activity, a M2 phenotypic biomarker, was
upregulated by the treatment of macrophages with conditioned media. Curcumin, 22-
oxacalcitriol, and LPS partially inhibited RAW 264.7 arginase activity in the presence of
4T1 breast cancer media. 22-oxacalcitriol increased the phagocytic ability of RAW 264.7
macrophages in the presence of M2 polarizing substances produced by the 4T1 breast
cancer cells. Also, LPS increased RAW 264.7 phagocytic ability in the presence of 4T1
breast cancer CM. This study looked at the potential substances that would possibly reverse the M2 tumor promoting macrophage phenotype seen in the breast cancer tumor
environment. / Includes bibliography. / Thesis (M.S.)--Florida Atlantic University, 2017. / FAU Electronic Theses and Dissertations Collection

Identiferoai:union.ndltd.org:fau.edu/oai:fau.digital.flvc.org:fau_34564
ContributorsLiddle, Genevieve M. (author), Hartmann, James X. (Thesis advisor), Florida Atlantic University (Degree grantor), Charles E. Schmidt College of Science, Department of Biological Sciences
PublisherFlorida Atlantic University
Source SetsFlorida Atlantic University
LanguageEnglish
Detected LanguageEnglish
TypeElectronic Thesis or Dissertation, Text
Format41 p., application/pdf
RightsCopyright © is held by the author, with permission granted to Florida Atlantic University to digitize, archive and distribute this item for non-profit research and educational purposes. Any reuse of this item in excess of fair use or other copyright exemptions requires permission of the copyright holder., http://rightsstatements.org/vocab/InC/1.0/

Page generated in 0.0058 seconds